1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > US Automated Microbiology Market 2015: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

Complete report $9,850.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.


“US Automated Microbiology Market 2015” is a new analysis of major business opportunities emerging in the US automated microbiology market during the next five years.  The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

 

Rationale


The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology.  The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.


The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems.  The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies.  The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans.  Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.


The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding US microbiology market, in evaluating emerging opportunities and developing effective business strategies.  


Market Segmentation Analysis


- Sales and market shares for major suppliers by individual test.


- Volume and sales forecasts for over 100 infectious disease assays

by individual test:


- Test volume estimates by method (molecular, serology/immunodiagnostics,

culture/microscopy).


- Review of the market dynamics, trends, structure, size, growth

and major suppliers.


Specimen Types


- Urine

- Sterile Fluids: Blood, Serum, CSF

- Throat Swabs, Respiratory Secretions

- Genital Secretions

- Stool

- Abscess/Wound

- Sputum

- Saliva


Applications


- Microbial Identification

- Antibiotic Susceptibility

- Urine Screening

- Blood Cultures


Review of Major Automated Systems


- Review of major automated molecular diagnostic, multipurpose, specialized,

microbial identification, antibiotic susceptibility, blood culture, urine screening,

and immunodiagnostic analyzers.


- The report profiles analyzers manufactured by Abbott, Alifax, Anagen,

BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad,

Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J,

Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens,

Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.


Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,

Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,

Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,

Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme,

Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,

Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.


Technology Review


- Assessment of molecular diagnostic, monoclonal antibody,

immunoassay, and other technologies and their potential

applications for the microbiology market.


- Global listings of companies developing or marketing microbiology

products by individual test.


Competitive Assessments


- Strategic assessments of major suppliers and emerging market entrants,

including their sales, product portfolios, marketing tactics, collaborative

arrangements and new products in R&D.


- The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies,

Arca Pharma, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux,

Bio-Rad, Biotest, Cepheid, CellMark Forensics/LabCorp, Decode Genetics, Diadexus, Diamedix, DiaSorin, Eiken Chemical,
Elitech Group, Enzo Biochem, Exact Sciences, Fujirebio, Grifols, Hologic/Gen-Probe, Illumina, ID Biomedical/GSK, Kreatech/Leica, Li-Cor Biosciences, Lonza, Monogram Biosciences, Myriad Genetics, Ortho-Clinical Diagnostics, Perkin Elmer/Caliper, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Sierra Molecular, Shimadzu,  Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.


Opportunities and Strategic Recommendations


- Emerging opportunities for new analyzers, reagents kits,

IT and other products with significant market appeal during the next five years.


- Design criteria for decentralized testing products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Contains 436 pages and 94 tables

“US Automated Microbiology Market 2015” is a new analysis of major business opportunities emerging in the US automated microbiology market during the next five years. The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Table Of Contents

US Automated Microbiology Market 2015: Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
I. Worldwide Market and Technology Overview
A. Introduction
1. Major Factors Affecting Market Penetration
of Microbiology Instrumentation
2. Traditional Practices
3. Technological Challenges
4. Automation: Impact on the Microbiology
Laboratory and the Patient
B. Major Specimen Types
1. Urine
2. Sterile Fluids: Blood, Serum, and CSF
3. Throat Swabs and Respiratory Secretions
4. Genital Secretions
5. Stool
6. Abscess/Wound
7. Sputum
8. Saliva
C. Test Applications
1. Microbial Identification
2. Antibiotic Susceptibility
3. Urine Screening
a. Photometry
b. Bioluminescence
c. Colorimetric Filtration
d. Enzymatic Detection
e. Optical Detection
4. Blood Cultures
D. Major Microbiology Automated and Semiautomated Systems
1. Multiple Purpose Microbiology Systems
2. Specialized Microbiology Systems
3. Molecular Diagnostic Systems
4. Immunodiagnostic Systems

E. Emerging Diagnostic Technologies
1. Molecular Diagnostics
a. DNA Sequencing
Introduction
Sequencing Methods
Autoradiography
The Human Genome Project
Sequencing Automation
Image Scanners
Fluorescent Detection
Gene Profiling
Gene Expression
Polymorphism Screening
Protein Interaction Networks
b. DNA And RNA Probe Technology
Basic Principles
Probe Preparation
The DNA Probe Test
- Sample Preparation
- Hybridization
- Separation
- Detection/Measurement
Test Formats
- Filter Hybridization
- Southern Blot
- Northern Blot
- In Situ Hybridization
- Others
Labeling Techniques
Amplification Methods
O Polymerase Chain Reaction
- Temperature Cyclers
- PCR Variations
* Immuno-PCR
* QC-PCR
* DAP-PCR
O Strand Displacement Activation
O TMA
O Ligase Chain Reaction

O Branched DNA
- Hybridization Protection Assay
O Nucleic-Acid Sequence-Based Amplification
O Self-Sustained Sequence Replicase
O Others
- Ampliprobe
- CAR
- CAS
- CPT
- Dendritic Polymer Technology
- ISO-CR
- LAT
- Probe
- RAMP
- Repair Chain Reaction
- Rolling Circles
- Sequence Independent Gene Amplification
- Sequence Initiation Reaction
- SISPA
- Solid Phase Amplification
c. Detection Technologies
Radioactive Methods
- Overview
- Major Isotopes
O P-32
O S-35
O H-3
O I-125
Non-Isotopic Methods
- Enzymatic Labels
- Chemical Labeling
O Indirect Chemical Labeling
O Direct Chemical Labeling
- Fluorescence
- Chemiluminescence
- Electrical Conductivity


d. Biochips: Genosensors, Microarrays,
and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

II. U.S.A.
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference

4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Pharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forenciscs/Lab Corp
- Decode Genetics
- Diadexus
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- ID Biomedical/GSK

- Kreatech/Leica
- Li-Cor Biosciences
- Lonza
- Monogram Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Sierra Molecular
- Shimadzu
- Takara Bio
- Tecan
- Thermo Fisher
- Wallac/PE
- Wako


List of Tables
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests

Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests

Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A.
Laboratories Performing Microbiology Tests by Market Segment
U.S.A.
Hospital Laboratories Performing Microbiology Tests by Bed Size
U.S.A.
Commercial/Private Laboratories Performing Microbiology Tests
by Annual Test Volume
U.S.A.
All Market Segments Microbiology Specimen Volume
U.S.A.
Hospital Laboratories Microbiology Specimen Volume
U.S.A.
Physician Offices/Group Practices Microbiology Specimen Volume
U.S.A.
Public Health Laboratories Microbiology Specimen Volume
U.S.A.
Commercial/Private Laboratories Microbiology Specimen Volume
U.S.A.
Microbiology Test Volume by Market Segment

U.S.A.
Microbiology Test Volume by Application
U.S.A.
Microbial Identification Test Volume by Market Segment
U.S.A.
Urine Screening Test Volume by Market Segment
U.S.A.
Blood Culture Test Volume by Market Segment
U.S.A.
Antibiotic Susceptibility Test Volume by Market Segment
U.S.A.
Microbiology Consumables Market by Application
U.S.A.
Microbiology Consumables Market by Market Segment
U.S.A.
Microbial Identification Consumables Sales by Market Segment
U.S.A.
Antibiotic Susceptibility Consumables Sales by Market Segment
U.S.A.
Blood Culture Consumables Sales by Market Segment
U.S.A.
Urine Screening Consumables Sales by Market Segment
U.S.A.
All Market Segments Infectious Disease Test Volume Forecast by Assay
U.S.A.
All Market Segments Infectious Disease Diagnostics Market Forecast by Test
U.S.A.
Infectious Disease Blood Screening NAT Volume Forecast by Assay

U.S.A.
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay
U.S.A.
HIV/AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A.
HIV/Hepatitis Blood Screening NAT Market Diagnostics Sales
by Major Supplier
U.S.A.
Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Giardia Testing Market Diagnostics Sales by Major Supplier

U.S.A.
Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Mycoplasma Testing Market Diagnostics Sales by Major Supplier

U.S.A.
Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A.
RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Tuberculosis Testing Market Diagnostics Sales by Major Supplier
U.S.A.
Molecular Diagnostics Market Sales and Shares of Major Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Competing in the Global Enteric Disease Testing Market

2016 Competing in the Global Enteric Disease Testing Market

  • $ 11500
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 7500
  • Industry report
  • September 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

World Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

  • $ 7500
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7500. This new 389-page report from VPGMarketResearch.com contains 97 tables and provides analysis of the global enteric ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.